Patel Sushil
Revolution Medicines, Inc. · Director
Patel Sushil serves as a Director at Revolution Medicines, Inc., where he has been involved in various strategic decisions within the healthcare sector. His recent trading activity reflects a focus on sale transactions, with a total of 17 sales reported from July 10, 2024, to July 1, 2026. Notably, his largest disclosed move occurred on April 7, 2026, involving a grant/exercise valued at approximately $2.9 million related to Replimune Group, Inc. (REPL). The disclosed amounts for his sales range from $204.5K to $166.1K, indicating a consistent engagement in the market.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $190k37.3k shares | SellMay 18, 2026 | $5.08 | $9.52 | |
| $111k10k shares | SellDec 2, 2025 | $11.13 | $9.52 | |
| $202k25.1k shares | SellMay 20, 2025 | $8.06 | $9.52 | |
| $124k10k shares | SellDec 16, 2024 | $12.42 | $9.52 | |
| $271k5k shares | SellOct 31, 2024 | $54.14 | $8.62 | |
| $271k5k shares | SellOct 31, 2024 | $54.14 | $184.44 | |
| $95k2.2k shares | SellJul 9, 2024 | $44.00 | $8.62 | |
| $95k2.2k shares | SellJul 9, 2024 | $44.00 | $184.44 |